252 related articles for article (PubMed ID: 33719971)
1. MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy.
Mathur P; Rani V
Curr Gene Ther; 2021; 21(4):313-326. PubMed ID: 33719971
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
[TBL] [Abstract][Full Text] [Related]
3. The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathy.
Abdel Rhman M; Owira P
J Pharm Pharmacol; 2022 Nov; 74(12):1663-1676. PubMed ID: 36130185
[TBL] [Abstract][Full Text] [Related]
4. Role of Non-coding RNA in Diabetic Cardiomyopathy.
Xia L; Song M
Adv Exp Med Biol; 2020; 1229():181-195. PubMed ID: 32285412
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides.
Ghosh N; Katare R
Cardiovasc Diabetol; 2018 Mar; 17(1):43. PubMed ID: 29566757
[TBL] [Abstract][Full Text] [Related]
6. Biological Functions and Clinical Prospects of Extracellular Non-Coding RNAs in Diabetic Cardiomyopathy: an Updated Review.
Yin Z; Chen C
J Cardiovasc Transl Res; 2022 Jun; 15(3):469-476. PubMed ID: 35175553
[TBL] [Abstract][Full Text] [Related]
7. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.
Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD
BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478
[TBL] [Abstract][Full Text] [Related]
8. Exosomal microRNAs: potential targets for the prevention and treatment of diabetic cardiomyopathy.
Zhang T; Gao Z; Chen K
J Cardiol; 2022 Nov; 80(5):423-431. PubMed ID: 35000826
[TBL] [Abstract][Full Text] [Related]
9. Targeting non-coding RNAs in sEVs: The biological functions and potential therapeutic strategy of diabetic cardiomyopathy.
Ding N; Yin Z; Chen C
Biomed Pharmacother; 2023 Jul; 163():114836. PubMed ID: 37156118
[TBL] [Abstract][Full Text] [Related]
10. Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.
Nandi SS; Mishra PK
Adv Exp Med Biol; 2018; 1056():47-59. PubMed ID: 29754174
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K/Akt signaling pathway via PIK3CA.
Yang X; Li X; Lin Q; Xu Q
Gene; 2019 Oct; 715():143995. PubMed ID: 31336140
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M; Li Y; Li S; Lv J
Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
[TBL] [Abstract][Full Text] [Related]
13. Diabetic cardiomyopathy--fact or fiction?
Maisch B; Alter P; Pankuweit S
Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
[TBL] [Abstract][Full Text] [Related]
14. Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs.
Macvanin MT; Gluvic Z; Radovanovic J; Essack M; Gao X; Isenovic ER
Front Endocrinol (Lausanne); 2023; 14():1124613. PubMed ID: 36950696
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy.
Yue Y; Meng K; Pu Y; Zhang X
Diabetes Res Clin Pract; 2017 Nov; 133():124-130. PubMed ID: 28934669
[TBL] [Abstract][Full Text] [Related]
16. Changes in microRNA Expression Profiles in Diabetic Cardiomyopathy Rats Following H3 Relaxin Treatment.
Zhang X; Liu M; Yang K; Chi J; Chen W; Shi Z; Liu W; Ma X; Yin X
J Cardiovasc Pharmacol; 2022 Apr; 79(4):530-538. PubMed ID: 34983906
[TBL] [Abstract][Full Text] [Related]
17. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.
Parim B; Sathibabu Uddandrao VV; Saravanan G
Heart Fail Rev; 2019 Mar; 24(2):279-299. PubMed ID: 30349977
[TBL] [Abstract][Full Text] [Related]
18. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
[TBL] [Abstract][Full Text] [Related]
19. LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives.
Tao H; Song ZY; Ding XS; Yang JJ; Shi KH; Li J
Endocrine; 2018 Nov; 62(2):281-291. PubMed ID: 30054866
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Diabetic Cardiomyopathy and Role of miRNA.
Ahmed U; Khaliq S; Ahmad HU; Ahmad I; Ashfaq UA; Qasim M; Masoud MS
Crit Rev Eukaryot Gene Expr; 2021; 31(1):79-92. PubMed ID: 33639058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
